Https%3a%2f%2fcdn.evbuc.com%2fimages%2f50612354%2f271641348539%2f1%2foriginal

Innovators in Therapeutics, a Student Speaker Series


Please join us for the Innovators in Therapeutics student speaker series organized by the Harvard-MIT Center for Regulatory Science and the Harvard Program in Therapeutic Science. The first installment of this series will feature John Maraganore, the CEO of Alnylam, and Sara Nochur, Alnylam’s Senior Vice President for Regulatory Affairs. Dr. Maraganore and Dr. Nochur will describe Alnylam's path through development and FDA approval of the first RNAi therapeutic, ONPATTRO™ (patisiran), for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis. Dr. Maraganore and Dr. Nochur will focus on the regulatory science aspects of gaining approval for this innovative therapeutic.



Prior to the seminar, please join us for a networking session that brings together faculty, students and trainees who are interested in translational research, pharmacology, biotechnology, and regulatory science. Following the speaking program, there will be a small group discussion for students and trainees to engage directly with the expert about the topic at hand. Participation in the small group discussion is limited to students who register and are confirmed prior to the event.

This event is free and open to the Boston research community. Please help us to plan by RSVPing here!





AGENDA


4:30 - 5:00pm: Pre-event reception (outside Cannon Room)


5:00 - 5:45pm: Innovators in Therapeutics with Alnylam's John Maraganore & Sara Nochur (Cannon Room)


5:45 - 6:15pm: [Limited Space] Student and Trainee Q&A with John Maraganore & Sara Nochur (Folin Wu Room)